Researcher
Emmanuel Andre
- Disciplines:Biochemistry and metabolism, Microbiology, Systems biology, Laboratory medicine, Medical biochemistry and metabolism
Affiliations
- Laboratory of Clinical Microbiology (Division)
Member
From26 Jan 2018 → 30 Sep 2022
Projects
1 - 10 of 11
- Modeling health emergency response strategies and capacities in the EUFrom23 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Antimicrobial resistance containment in hospital settings in Francophone West AfricaFrom1 Sep 2023 → TodayFunding: VLIR-UOS International Training Program (ITP)
- Decrypting the motivation and epidemiological determinants associated with citizen engagement in disease surveillance, prevention and control activities related to emerging infectious diseasesFrom1 May 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Optimizing outbreak data management tools using epidemiological and genomic data collected during the COVID-19 pandemic, and integrating artificial intelligence tools to allow for monitoring the evolution of an outbreak in real timeFrom6 Feb 2023 → TodayFunding: FWO fellowships
- Environmental sampling as a tool to monitor enteric virus epidemiologyFrom1 Feb 2023 → TodayFunding: FWO fellowships
- Scalable recall-based contact tracing for the next pandemicFrom17 Nov 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Impact of diagnostic delays and short treatment regimens on outcomes of rifampicin-resistant tuberculosis patients in CameroonFrom29 Jun 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Towards a Learning and Adaptive European pandemic Preparedness and emergency response SystemFrom1 Jan 2022 → 31 Dec 2023Funding: BOF - various
- Leveraging indoor positioning systems for infectious disease controlFrom1 Jan 2021 → 31 Dec 2022Funding: IOF - technology validation in lab
- Point of care gathering and real-time utilization of smartphone generated movement traces of patients for infectious disease containment in the community.From6 Aug 2020 → TodayFunding: FWO Strategic Basic Research Grant
Publications
21 - 30 of 75
- Risk factors for SARS-CoV-2 transmission in student residences: a case-ascertained study(2022)
Authors: Geert Molenberghs, Caspar Geenen, Sarah Gorissen, Emmanuel Andre
- Genomic evidence of co-identification with Omicron and Delta SARS-CoV-2 variants: a report of two cases(2022)
Authors: Lize Cuypers, Emmanuel Andre, Guy Baele, Piet Maes
Pages: 212 - 214 - The role of airborne transmission in a large single source outbreak of SARS-CoV-2 in a Belgian nursing home in 2020(2022)
Authors: Lize Cuypers, Guy Baele, Emmanuel Andre, Piet Maes
- Empirical evidence on the efficiency of backward contact tracing in COVID-19(2022)
Authors: Caspar Geenen, Sarah Gorissen, Emmanuel Andre
- Serial Intervals for SARS-CoV-2 Omicron and Delta Variants, Belgium, November 19-December 31, 2021(2022)
Authors: Emmanuel Andre
Pages: 1699 - 1702 - Early SARS-CoV-2 Reinfections within 60 Days and Implications for Retesting Policies(2022)
Authors: Louis Nevejan, Lize Cuypers, Lies Laenen, Liselotte Van Loo, François Vermeulen, Stefanie Desmet, Katrien Lagrou, Piet Maes, Emmanuel Andre
Pages: 1729 - 1731 - Nationwide Harmonization Effort for Semi-Quantitative Reporting of SARS-CoV-2 PCR Test Results in Belgium(2022)
Authors: Lize Cuypers, Lies Laenen, Stijn Jonckheere, Kristel Van Laethem, Els Dequeker, Stefanie Desmet, Piet Maes, Katrien Lagrou, Emmanuel Andre
- Two Separate Clusters of SARS-CoV-2 Delta Variant Infections in a Group of 41 Students Travelling from India: An Illustration of the Need for Rigorous Testing and Quarantine(2022)
Authors: Lize Cuypers, Sarah Gorissen, Marc Van Ranst, Johan Van Weyenbergh, Piet Maes, Guy Baele, Pieter Vermeersch, Emmanuel Andre
- Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies(2022)
Authors: Piet Maes, Lize Cuypers, Guy Baele, Emmanuel Andre
Pages: 1297 - + - Lower persistence of anti-nucleocapsid compared to anti-spike antibodies up to one year after SARS-CoV-2 infection(2022)
Authors: Natalie Lorent, Gijs Van Pottelbergh, Lode Godderis, Marc Van Ranst, Emmanuel Andre, Katrien Lagrou, Pieter Vermeersch